{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:09:00Z","timestamp":1762506540385},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00228-015-1850-y","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T04:21:07Z","timestamp":1430713267000},"page":"759-766","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study"],"prefix":"10.1007","volume":"71","author":[{"given":"Elisa","family":"Mart\u00edn-Merino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"de Abajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"issue":"6","key":"1850_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7(6):803\u2013813. doi: 10.1586\/eci.11.66 , quiz 814\u2013805","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"1850_CR2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","volume":"64","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J (2005) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of anti-epileptics. Neurology 64(7):1134\u20131138. doi: 10.1212\/01.wnl.0000156354.20227.f0","journal-title":"Neurology"},{"issue":"24","key":"1850_CR3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F et al (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333(24):1600\u20131607. doi: 10.1056\/nejm199512143332404","journal-title":"N Engl J Med"},{"issue":"4","key":"1850_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","volume":"94","author":"E Letko","year":"2005","unstructured":"Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS (2005) Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol : Off Publ Am Coll Allergy Asthma Immunol 94(4):419\u2013436. doi: 10.1016\/s1081-1206(10)61112-x , quiz 436\u2013418, 456","journal-title":"Ann. Allergy Asthma Immunol. : Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"1","key":"1850_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study. J Invest Dermatol 128(1):35\u201344. doi: 10.1038\/sj.jid.5701033","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1850_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92\u201396","journal-title":"Arch Dermatol"},{"issue":"8","key":"1850_CR7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schr\u00f6der W, Roujeau JC (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138(8):1019\u20131024","journal-title":"Arch Dermatol"},{"issue":"1","key":"1850_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","volume":"126","author":"JC Roujeau","year":"1990","unstructured":"Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP (1990) Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985. Arch Dermatol 126(1):37\u201342","journal-title":"Arch Dermatol"},{"issue":"1","key":"1850_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","volume":"126","author":"HL Chan","year":"1990","unstructured":"Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM (1990) The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 126(1):43\u201347","journal-title":"Arch Dermatol"},{"issue":"6","key":"1850_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","volume":"127","author":"E Sch\u00f6pf","year":"1991","unstructured":"Sch\u00f6pf E, St\u00fchmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127(6):839\u2013842","journal-title":"Arch Dermatol"},{"issue":"8","key":"1850_CR11","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","volume":"126","author":"L Naldi","year":"1990","unstructured":"Naldi L, Locati F, Marchesi L, Cainelli T (1990) Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 126(8):1103\u20131104","journal-title":"Arch Dermatol"},{"issue":"6","key":"1850_CR12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","volume":"127","author":"BL Strom","year":"1991","unstructured":"Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Shaw M, Tilson HH, Joseph M, Dai WS, Chen D et al (1991) A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol 127(6):831\u2013838","journal-title":"Arch Dermatol"},{"issue":"7","key":"1850_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","volume":"49","author":"B Rzany","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, Schr\u00f6der W, Stocker U, Mueller J, Holl\u00e4nder N, Bruppacher R, Sch\u00f6pf E (1996) Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry. J Clin Epidemiol 49(7):769\u2013773","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1850_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 58(1):33\u201340. doi: 10.1016\/j.jaad.2007.08.039","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1850_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0009-9236(95)90078-0","volume":"58","author":"OM Bakke","year":"1995","unstructured":"Bakke OM, Manocchia M, de Abajo F, Kaitin KI, Lasagna L (1995) Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin Pharmacol Ther 58(1):108\u2013117. doi: 10.1016\/0009-9236(95)90078-0","journal-title":"Clin Pharmacol Ther"},{"key":"1850_CR16","unstructured":"Tetrazepam containing medicines suspended across the EU (2014) European Medicines Agency. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Tetrazepam_containing_medicinal_products\/human_referral_prac_000015.jsp&mid=WC0b01ac05805c516f . Accessed 4 July 2014"},{"key":"1850_CR17","author":"J Kuepper-Nybelen","year":"2014","unstructured":"Kuepper-Nybelen J, Thuermann P, Schubert I (2014) Frequency of tetrazepam prescription: estimates for Germany. Pharmacoepidemiol Drug Saf. doi: 10.1002\/pds.3672","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1850_CR18","unstructured":"BIFAP Base de Datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria. http:\/\/bifap.aemps.es\/ . Accessed 05 March 2015"},{"key":"1850_CR19","volume-title":"ICPC. International classification of primary care","author":"H Lamberts","year":"1987","unstructured":"Lamberts H, Wood M (1987) ICPC. International classification of primary care. Oxford University Press, Oxford"},{"issue":"1","key":"1850_CR20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H (2010) ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case\u2013control analysis. Clin Pharmacol Ther 88(1):60\u201368. doi: 10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1850_CR21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pds.3371","volume":"22","author":"N Moore","year":"2013","unstructured":"Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jove J, Pariente A, Blin P, Benichou J, Begaud B (2013) Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf 22(2):160\u2013167. doi: 10.1002\/pds.3371","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1850_CR22","unstructured":"Greenland S, Rothman KJ (2008) Introduction to stratified data. In: Rothman KJ, Greenland S, Lash TL (eds) Modern epidemiology, 3rd edn. Philadelphia, PA: Lippincott, Williams & Wilkins."},{"issue":"172","key":"1850_CR23","first-page":"1337","volume":"50","author":"B Bady","year":"1969","unstructured":"Bady B, Trillet M, Aimard G, Girard R (1969) Use of tetrazepam in the treatment of contractures during neurological diseases. J Med Lyon 50(172):1337\u20131342","journal-title":"J Med Lyon"},{"issue":"12","key":"1850_CR24","first-page":"1081","volume":"106","author":"J Boudouresque","year":"1969","unstructured":"Boudouresque J, Daniel F (1969) 4261 CB tetrazepam trial in a series of 42 patients with hypertonia of different origin. Mars Med 106(12):1081\u20131085","journal-title":"Mars Med"},{"issue":"1","key":"1850_CR25","first-page":"5","volume":"84","author":"M Pellkofer","year":"1989","unstructured":"Pellkofer M, Paulig M (1989) Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities. Med Klin (Munich, Germany : 1983) 84(1):5\u20138","journal-title":"Med. Klin. (Munich, Germany : 1983)"},{"key":"1850_CR26","unstructured":"Enquete officielle sur les effects indesirables du tetrazepam (2012) Commission Nationale de Pharmacovigilance. Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/c9e15dee904acc094f9b909eea1634a2.pdf . Accessed 14 July 2014"},{"issue":"6","key":"1850_CR27","first-page":"705","volume":"13","author":"B Proy-Vega","year":"2014","unstructured":"Proy-Vega B, Aguirre C, de Groot P, Solis-Garcia del Pozo J, Jordan J (2014) On the clinical evidence leading to tetrazepam withdrawal. Expert Opin Drug Saf 13(6):705\u2013712. doi: 10.1517\/14740338.2014.915023","journal-title":"Expert Opin Drug Saf"},{"key":"1850_CR28","unstructured":"Tetrazepam adverse events and side effects reported to the FDA (AERS). DrugCite. Food and Drug Administration. http:\/\/www.drugcite.com\/?q=tetrazepam . Accessed 15 July 2014"},{"issue":"11","key":"1850_CR29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1034\/j.1398-9995.1999.00362.x","volume":"54","author":"MD Pozo Del","year":"1999","unstructured":"Del Pozo MD, Blasco A, Lobera T (1999) Tetrazepam allergy. Allergy 54(11):1226\u20131227","journal-title":"Allergy"},{"issue":"2","key":"1850_CR30","first-page":"55","volume":"26","author":"I Sanchez","year":"1998","unstructured":"Sanchez I, Garcia-Abujeta JL, Fernandez L, Rodriguez F, Quinones D, Duque S, Lopez R, Jerez J (1998) Stevens-Johnson syndrome from tetrazepam. Allergol Immunopathol 26(2):55\u201357","journal-title":"Allergol Immunopathol"},{"issue":"3","key":"1850_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0536.2002.470302.x","volume":"47","author":"C Pirker","year":"2002","unstructured":"Pirker C, Misic A, Brinkmeier T, Frosch PJ (2002) Tetrazepam drug sensitivity\u2014usefulness of the patch test. Contact Dermatitis 47(3):135\u2013138","journal-title":"Contact Dermatitis"},{"issue":"2","key":"1850_CR32","first-page":"187","volume":"56","author":"R Lagnaoui","year":"2001","unstructured":"Lagnaoui R, Ramanampamonjy R, Julliac B, Haramburu F, Ticolat R (2001) Fatal toxic epidermal necrolysis associated with tetrazepam. Therapie 56(2):187\u2013188","journal-title":"Therapie"},{"issue":"4","key":"1850_CR33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-4632.2006.02654.x","volume":"45","author":"F Delesalle","year":"2006","unstructured":"Delesalle F, Carpentier O, Guatier S, Delaporte E (2006) Toxic epidermal necrolysis caused by tetrazepam. Int J Dermatol 45(4):480. doi: 10.1111\/j.1365-4632.2006.02654.x","journal-title":"Int J Dermatol"},{"issue":"4","key":"1850_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0536.1990.tb01587.x","volume":"22","author":"JG Camarasa","year":"1990","unstructured":"Camarasa JG, Serra-Baldrich E (1990) Tetrazepam allergy detected by patch test. Contact Dermatitis 22(4):246","journal-title":"Contact Dermatitis"},{"issue":"3\u20134","key":"1850_CR35","first-page":"236","volume":"17","author":"C Loncar","year":"2005","unstructured":"Loncar C, Franic T, Bilusic M (2005) Toxic epidermal necrolysis caused by flurazepam? Psychiatr Danub 17(3\u20134):236\u2013239","journal-title":"Psychiatr Danub"},{"issue":"6","key":"1850_CR36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2133.1996.d01-1111.x","volume":"135","author":"P Redondo","year":"1996","unstructured":"Redondo P, Vicente J, Espana A, Subira ML, De Felipe I, Quintanilla E (1996) Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol 135(6):999\u20131002","journal-title":"Br J Dermatol"},{"issue":"6","key":"1850_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1726-4901(09)70150-9","volume":"68","author":"PH Huang","year":"2005","unstructured":"Huang PH, Tsai WJ (2005) Chlordiazepoxide-induced Stevens-Johnson syndrome. J Chin Med Assoc : JCMA 68(6):276\u2013278. doi: 10.1016\/s1726-4901(09)70150-9","journal-title":"J. Chin. Med. Assoc. : JCMA"},{"issue":"1","key":"1850_CR38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-4632.2009.03865.x","volume":"48","author":"I Ertam","year":"2009","unstructured":"Ertam I, Sezgin AO, Unal I (2009) A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment. Int J Dermatol 48(1):98\u201399. doi: 10.1111\/j.1365-4632.2009.03865.x","journal-title":"Int J Dermatol"},{"issue":"7","key":"1850_CR39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1528-1167.2011.03075.x","volume":"52","author":"VH Machado","year":"2011","unstructured":"Machado VH, Palmini A, Bastos FA, Rotert R (2011) Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: a \u2018proof of concept\u2019, open label study. Epilepsia 52(7):1303\u20131310. doi: 10.1111\/j.1528-1167.2011.03075.x","journal-title":"Epilepsia"},{"issue":"1","key":"1850_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"C Huerta","year":"2013","unstructured":"Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H (2013) Prevalence of use of benzodiazepines and related drugs in seven European databases: a cross-national descriptive study from the PROTECT-EU project. Pharmacoepidemiol Drug Saf 22(1):1\u2013512. doi: 10.1002\/pds.3512","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1850_CR41","unstructured":"The RegiSCAR Project. (2014) RegiSCAR. http:\/\/www.regiscar.org\/ . Accessed 3 October 2014"},{"issue":"1","key":"1850_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"M Mockenhaupt","year":"2013","unstructured":"Mockenhaupt M, Sekula S, Lebrun-Vignes B, Roujeau JC (2013) The risk of tetrazepam to induce severe cutaneous adverse reactions. Pharmacoepidemiol Drug Saf 22(1):1\u2013521. doi: 10.1002\/pds.3512","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1850_CR43","unstructured":"PIELenRed (2014) Consorcio PIELenRed. http:\/\/pielenred.hol.es\/PIELenRed\/tag\/pielenred\/ . Accessed 8 October 2014"},{"issue":"13","key":"1850_CR44","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","volume":"249","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249(13):1743\u20131745","journal-title":"JAMA"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1850-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1850-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1850-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T13:52:31Z","timestamp":1566654751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1850-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1850-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}